Clinical expert round table discussion (session 3) at the Margaux Conference on Critical Illness: the role of activated protein C in severe sepsis.
Bernard
G
G
Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Artigas
A
A
Dellinger
P
P
Esmon
C
C
Faist
E
E
Faust
S N
SN
Fischer
C J
CJ
Fumagalli
R
R
grinnell
B W
BW
Sprung
C
C
D001778:Blood Coagulation Disorders / Q000097:blood / Q000276:immunology / Q000382:microbiology*; D006801:Humans; D007249:Inflammation; D011486:Protein C / Q000276:immunology / Q000502:physiology* / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000276:immunology / Q000627:therapeutic use; D018805:Sepsis / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D013917:Thrombin / Q000502:physiology; D013927:Thrombosis / Q000382:microbiology; D016896:Treatment Outcome
D011486:Protein C; D011994:Recombinant Proteins; D013917:Thrombin; C421124:drotrecogin alfa activated